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considering seasonal differences. As for some pollutants, e. g. benzene, assessment values are reached or 
exceeded, health effects cannot be excluded. Further monitoring and public health strategies targeted to parents 
of young children are warranted. Acknowledgements GerES IV was funded by the German Ministry of Education 
and Research and the Ministry for the Environment, Nature Conservation, Building and Nuclear Safety. GerES 
IV field work was carried out by the Robert Koch Institute. 
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Abstract: Six volunteers spent 6 hours in an exposure chamber on 2 separate occasions during which the air 
contained elevated levels of DnBP. For both sessions, volunteers were only clad in shorts, facilitating the air-to-
skin transfer of DnBP. In one of the sessions, the volunteers breathed clean air from an airtight helmet, 
restricting exposure to the dermal pathway. In the other session, they did not wear the helmet and exposure was 
via both inhalation and dermal pathways. One urination event occurred during the chamber exposure, and all 
volunteers collected full urine samples for 50 hours after leaving the chamber. Levels of DnBP metabolites in the 
urine were above background while in the chamber and for about 36 hours after leaving the chamber. These 
experiments indicated that the contribution of the dermal pathway to DnBP uptake was roughly 80% of the 
inhalation pathway. Prior to these experiments, a transient air-to-skin-to-blood model had been published. A 
separate publication described a simple pharmacokinetic (PK) model to predict urine concentrations of DnBP 
metabolites following an oral exposure. The transient air-to-skin-to blood model was applied to this experiment 
to predict the flux of DnBP to blood and linked with the PK model predicting the appearance of DnBP 
metabolites in urine. When applied to the data set, it was found that the model reasonably predicted the urine 
concentrations for the urine event in the chamber and the first few events upon leaving the chamber, but then 
the linked model began over-predicting metabolite excretions by roughly an order of magnitude. It is believed 
that when participants donned clothing after leaving the chamber, some of the residual DnBP sorbed in the skin 
was removed by the clothing; this sink was not accounted for in the linked model. This presentation will review 
the experiments, the data and models, and the linked model results. Efforts to develop a clothing removal 
algorithm will be summarized. 
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Abstract: EPA’s Chemical Safety for Sustainability (CSS) research program has been developing new ways to 
prioritize chemicals used in consumer products and articles. Using a risk-based methodology to account for both 
toxicity and exposure offers a comprehensive and systematic approach toward prioritization. The purpose of this 
prioritization initially is to identify those chemicals for which typical product usage rates may lead to undesirable 
exposures, and ultimately to identify potentially problematic chemicals before they even reach the marketplace. 
We developed a flexible dashboard-type chemical prioritization tool that ranks exposures from consumer 
products accounting for product formulation and use; physical-chemical properties (e.g., partitioning 
coefficients); and user exposure factors, activity patterns, and product use profiles. Additionally, the tool 
incorporates route- and chemical-specific internal dose predictions that consider absorption, distribution, 
metabolism, and excretion (ADME) processes allowing for better comparison of toxicity and exposure estimates. 
The tool indicates products likely to be in specific microenvironments, along with the ways people will contact 
chemicals in these products, thus allowing better screening and ranking of exposure in a high throughput 
environment. Currently, the tool considers seven pathways of exposure for 451 chemicals present in 946 
separate consumer products with the ability to add more chemicals and products as information becomes 
available. In this presentation, the tool is evaluated by comparing the predicted rank order of chemical 
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